Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20201101049215N1Phase 3Completed
Phase 3, randomised, double-blind trial of mometasone in hand dermatitis (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Hand Eczema Severity Index change and Dermatology Life Quality Index change. Started Nov 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20201101049215N1.